You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
特一藥業(002728.SZ)與廣滕醫藥擬開展仿製藥聯合研究開發和合作經營
格隆匯 12-25 17:55

格隆匯12月25日丨特一藥業(002728.SZ)公佈,公司與廣滕醫藥(深圳)有限公司(“廣滕醫藥”)於2019年12月23日在台山市簽訂了《項目合作合同》,雙方擬開展仿製藥聯合研究開發和合作經營。

共同開發及仿製化學制劑藥;並對開發及仿製且註冊成功的仿製藥品共同經營。前期開發的產品包括呼吸系統、腸胃系統及兒童用藥領域,聚焦於這些領域的新型藥物製劑的研製,重點包括口服固體、口服液體緩控釋製劑的研製及相關原料藥。

通過此次合同的簽署,有利於合作雙方整合和發揮各自資源優勢,在仿製藥聯合研究開發方面展開深度合作,實現優勢互補、互利互贏,符合公司的整體戰略佈局。若後續具體項目開展,將為公司的發展帶來積極的影響,符合公司股東的長遠利益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account